Heart Test Laboratories announced the close of a non-dilutive financing, with $1.9 million in net proceeds. The unsecured loan note has an 18-month maturity date and follows the recent 12-month extension of a $500,000 loan note to September 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSCS:
- HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission
- HSCS Upcoming Earnings Report: What to Expect?
- HeartSciences raised $10.3M in proceeds from stock sales , FDA submission close
- HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results
- Heart Test Laboratories announces analysis on MyoVista wavECG potential